Company profile: Reverse Medical
1.1 - Company Overview
Company description
- Provider of commercial-stage medical devices focused on revascularizing patients experiencing acute ischemic stroke.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reverse Medical
Cefaly Technology
HQ: Belgium
Website
- Description: Provider of non-invasive, drug-free migraine therapy and management solutions: the CEFALY e-TNS device to relieve pain and reduce migraine frequency; CEFALY Connected, a Bluetooth version syncing with the CeCe Migraine Management app for monitoring; and the CeCe app to track triggers, symptoms and treatments. Activities span biotechnology, pharmaceutical and medical devices with university research collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cefaly Technology company profile →
Phenox
HQ: Germany
Website
- Description: Provider of neuroradiological and radiological medical devices for treating acute ischemic stroke and intracranial aneurysms, including mechanical thrombectomy devices (pRESET), flow modulation devices (p64), bifurcation aneurysm implants (pCONUS), self-expanding stent systems (pEGASUS), and antithrombogenic HPC coatings that reduce thrombus formation by preventing platelet adhesion.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phenox company profile →
Aelis Farma
HQ: France
Website
- Description: Provider of signaling-specific therapeutics targeting GPCRs, notably the CB1 receptor, including AEF0117 for cannabis-related disorders, AEF0217 for cognitive deficits (initially Down syndrome, with potential for Fragile X syndrome and aging), and CB1-SSi inhibitors that selectively inhibit pathological CB1 hyperactivity without affecting normal brain functions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aelis Farma company profile →
Pharmaleads
HQ: France
Website
- Description: Provider of analgesic drug development focused on DENKIs, a new class of analgesics derived from highly potent and specific enkephalinase inhibitors, aiming to deliver improved pain relief for patients with severe chronic and acute pain without the side effects associated with other classes of analgesics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmaleads company profile →
Trophos
HQ: France
Website
- Description: Provider of clinical-stage pharmaceutical R&D developing innovative therapeutics for under-served needs in neurology and cardiology, with a pipeline of original molecules targeting motoneuron diseases such as amyotrophic lateral sclerosis (ALS).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trophos company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reverse Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reverse Medical
2.2 - Growth funds investing in similar companies to Reverse Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reverse Medical
4.2 - Public trading comparable groups for Reverse Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →